Bayer plans US expansion despite blood thinner drug setback
By Patrick Wingrove SAN FRANCISCO (Reuters) – Germany’s Bayer will continue its expansion into the U.S. despite its November announcement that its promising blood thinner candidate failed to demonstrate superiority over a…